Literature DB >> 31326776

Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.

Robert D Ashford1, Austin M Brown2, Jessica McDaniel2, Jenna Neasbitt3, Chad Sobora4, Robert Riley4, Lesley Weinstein4, Aaron Laxton4, Justin Kunzelman5, Kyle Kampman6, Brenda Curtis7.   

Abstract

Opioid use disorder (OUD) and opioid-related overdose mortality are major public health concerns in the United States. Recently, several community-based and professional innovations - including hybrid recovery community organizations, peer-based emergency department warm handoff programs, emergency department buprenorphine induction, and low-threshold OUD treatment programs - have emerged or expanded in an effort to address significant obstacles to providing patients the care needed for OUD and to reduce the risk of overdose. Additional innovations are needed to address the crisis. Building upon the foundational frameworks of each of these recent innovations, a new model of OUD pharmacotherapy is proposed and discussed: the Recovery Community Center Office-Based Opioid Treatment model. Additionally, two potential implementation scenarios, the overdose and non-overdose event protocols, are detailed for communities, peers, and practitioners interested in implementing the model. Potential barriers to implementation of the model include service reimbursement, licensing regulations, and organizational concerns. Future research should seek to validate the model and to identify actual implementation and sustainability barriers and best practices.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Low threshold; Office-based opioid treatment; Opioid use disorder; Overdose; Peer services; Recovery community organizations

Year:  2019        PMID: 31326776      PMCID: PMC7286074          DOI: 10.1016/j.addbeh.2019.106031

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  36 in total

1.  Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.

Authors:  Phoebe A Cushman; Jane M Liebschutz; Bradley J Anderson; Merredith R Moreau; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2016-06-11

2.  Drug Overdose Deaths in the United States, 1999-2016.

Authors:  Holly Hedegaard; Margaret Warner; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2017-12

3.  Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

Authors:  David A Fiellin; Michael V Pantalon; Marek C Chawarski; Brent A Moore; Lynn E Sullivan; Patrick G O'Connor; Richard S Schottenfeld
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

4.  Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.

Authors:  Christopher M Jones; Elinore F McCance-Katz
Journal:  Addiction       Date:  2018-10-15       Impact factor: 6.526

Review 5.  Contemporary addiction treatment: a review of systems problems for adults and adolescents.

Authors:  A Thomas McLellan; Kathleen Meyers
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

Review 6.  Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.

Authors:  P Todd Korthuis; Dennis McCarty; Melissa Weimer; Christina Bougatsos; Ian Blazina; Bernadette Zakher; Sara Grusing; Beth Devine; Roger Chou
Journal:  Ann Intern Med       Date:  2016-12-06       Impact factor: 25.391

7.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

8.  Community-based opioid overdose prevention programs providing naloxone - United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-02-17       Impact factor: 17.586

9.  Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.

Authors:  Elenore Patterson Bhatraju; Ellie Grossman; Babak Tofighi; Jennifer McNeely; Danae DiRocco; Mara Flannery; Ann Garment; Keith Goldfeld; Marc N Gourevitch; Joshua D Lee
Journal:  Addict Sci Clin Pract       Date:  2017-02-28

10.  Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.

Authors:  Robert D Ashford; Brenda Curtis; Austin M Brown
Journal:  Harm Reduct J       Date:  2018-10-22
View more
  3 in total

1.  Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017-2018.

Authors:  Lara Carson Weinstein; Qais Iqbal; Amy Cunningham; Robin Debates; Greg Landistratis; Patrick Doggett; Alexis Silverio
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

2.  Inpatient Opioid Use Disorder and Social Determinants of Health: A Nationwide Analysis of the National Inpatient Sample (2012-2014 and 2016-2017).

Authors:  Saanie Sulley; Memory Ndanga
Journal:  Cureus       Date:  2020-11-03

Review 3.  Identification and Management of Opioid Use Disorder in Primary Care: an Update.

Authors:  Joseph H Donroe; Elenore P Bhatraju; Judith I Tsui; E Jennifer Edelman
Journal:  Curr Psychiatry Rep       Date:  2020-04-13       Impact factor: 5.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.